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Abstract
Acetylation is mediated by acetyltransferases and deacetylases, and occurs not only on histones but also on diverse
proteins. Although histone acetylation in chromatin structure and transcription has been well studied, the biological roles of
non-histone acetylation remain elusive. Histone deacetylase 6 (Hdac6), a member of the histone deacetylase (HDAC) family,
is a unique deacetylase that localizes to cytoplasm and functions in many cellular events by deacetylating non-histone
proteins including a-tubulin, Hsp90, and cortactin. Since robust expression of Hdac6 is observed in brain, it would be
expected that Hdac6-mediated reversible acetylation plays essential roles in CNS. Here we demonstrate the crucial roles of
Hdac6 deacetylase activity in the expression of emotional behavior in mice. We found that Hdac6-deficient mice exhibit
hyperactivity, less anxiety, and antidepressant-like behavior in behavioral tests. Moreover, administration of Hdac6-specific
inhibitor replicated antidepressant-like behavior in mice. In good agreement with behavioral phenotypes of Hdac6-deficient
mice, Hdac6 dominantly localizes to the dorsal and median raphe nuclei, which are involved in emotional behaviors. These
findings suggest that HDAC6-mediated reversible acetylation might contribute to maintain proper neuronal activity in
serotonergic neurons, and also provide a new therapeutic target for depression.
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Introduction
Acetylation of the e-amino group of lysine is a reversible post-
translational modification mediated by acetyltransferases and
deacetylases. This type of acetylation is not restricted to histones
but also occurs on diverse proteins and affects functions such as
DNA binding, protein-protein interaction, enzymatic activity, and
stability. Therefore, lysine acetylation emerges as an important
post-translational modification that regulates a wide range of
cellular processes (reviewed in [1]).
Histone deacetylases (HDACs) are a family of enzymes with 18
isoforms in mammals, and are grouped into four classes by
sequence homology [2]. HDAC6 belongs to class II, and has a
unique structure with two catalytic domains and a C-terminal
BUZ domain that binds ubiquitin. HDAC6 gene is located on X
chromosome both in mice and human genome [3,4]. In mice,
Hdac6 protein is broadly expressed in multiple tissues, particularly
abundant in the brain and testis (Fig. S1) [5]. HDAC6 is known to
be a multi-functional cytoplasmic deacetylase that controls cell
motility [6–9], endocytosis [10], vesicle transport [11], glucocor-
ticoid receptor maturation [12], autophagic protein degradation
[13–15], and aggresome formation [16] by deacetylating a-
tubulin, cortactin, and Hsp90. These cellular events are closely
related to the acquisition and maintenance of proper function in
neurons. For example, at synapses, vesicle transport and
endocytosis are underlying mechanisms for neurotransmitter
release and recycling. Glucocorticoid receptor maturation is
necessary for the negative feedback regulation of stress at the
hippocampus [17]. Autophagic protein degradation and aggre-
some formation are a part of the quality control of proteins, and
their disturbance leads to neurodegenerative disorders [18].
Despite the fact that Hdac6 protein is abundantly expressed in
mice brain, the physiological implications of Hdac6 as well as non-
histone acetylation in neural function are poorly understood. In
this study, we found that Hdac6 is highly expressed in serotonergic
neuron, and that loss of Hdac6 deacetylase activity leads to
hyperactivity, less-anxiety and antidepressant-like behavior in
mice. Our findings suggest that Hdac6-mediated non-histone
deacetylation plays crucial roles in the expression of emotional
behaviors.
Results
Hdac6 is localized to serotonergic neurons in raphe
nuclei
To study the physiological implications of Hdac6 in CNS, we
first examined the distribution of Hdac6 in mouse brain by using
specific antibody for mouse Hdac6. We found robust expression of
Hdac6 in the medial and dorsal raphe nuclei (Fig. 1A), while
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6Figure 1. Strong expression of Hdac6 in raphe nuclei. (A–C) Hdac6 distribution in mouse brain. Hdac6 protein is visualized by an antibody to
Hdac6 (green: each right panel) in the coronal sections of adult mouse brain spanning raphe nuclei (A), hippocampus (B), and motor cortex (C).
Nucleus is visualized by DAPI staining (each left panel). Arrowheads indicate Hdac6-positive cells magnified in insets. (D) Coexpression of Hdac6 with
Tph2 in dorsal raphe neuron. The coronal brain sections of the dorsal raphe from WT (upper panels) and Hdac6 KO mice (lower panels) were double
immunostained for Hdac6 (red) and Tph2 (green), a marker of mature serotonin neuron. No signal was detected with anti-Hdac6 in Hdac6 KO mice.
Merged images were shown in right panels (blue: DAPI staining). (E) HDAC6 expression in human brainstem. HDAC6 is visualized by antibody to
HDAC6 in the horizontal sections of the postmortem human brainstem spanning raphe nuclei, locus ceruleus, and substantia nigra. DR, dorsal raphe
nucleus; MnR, median raphe nucleus; Aq, aqueduct. Scale bars, 100 mm.
doi:10.1371/journal.pone.0030924.g001
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(Fig. 1B), cerebral cortex (Fig. 1C), and other brain regions (data
not shown). In the medial and dorsal raphe nuclei of the WT
brain, Hdac6 signal was almost exclusively co-localized with
tryptophan hydroxylase 2 (Tph2) that was used as a marker for
serotonin neuron (Fig. 1D) [19]. No signal was detected with
Hdac6 antibody in where Tph2 signal was positive in raphe nuclei
of Hdac6 KO mice (Fig. 1D), confirming the specificity of our
antibody. These results clearly indicated that mature serotonergic
neurons highly express Hdac6 in mice. Similar distribution of
HDAC6 was observed in human postmortem brain with
additional expression of HDAC6 in substantia nigra and locus
ceruleus (Fig. 1E).
The ascending serotonergic projections are derived largely from
raphe nuclei and the serotonergic system contributes to regulate
emotional behaviors. Indeed, the central serotonergic system is
considered to be closely associated with the pathogenesis of
psychiatric diseases such as depression, schizophrenia, or some
anxiety disorders [20]. Therefore, these results raise the possibility
that HDAC6 is involved in the expression of emotional behaviors.
Hdac6-deficient mice show emotional abnormalities
Hdac6-deficient (KO) mice are viable and fertile, and develop
normally, regardless of the hyperacetylation of a-tubulin in most
tissues [5]. Our histological examination revealed no obvious
difference between wild-type (WT) and Hdac6 KO mouse brains
(data not shown). To determine whether Hdac6 KO mice suffer
from emotional abnormality, we performed a series of behavioral
tests. In the open field test, total distance traveled, an index of
activity, was significantly elevated in Hdac6 KO mice compared
with that in WT mice (145% on average; p,0.001), while there
were no significant differences between WT and KO mice in the
number of entries into the center zone, which is an index of
anxiety (Fig. 2A). These data suggest that Hdac6 KO mice suffer
from hyperactivity under novel environment. Next, we conducted
an elevated plus-maze test, a commonly used test for assessing
anxiety. Mice normally avoid the open arms (OAs) of the elevated
plus-maze owing to anxiety. In this test, Hdac6 KO mice showed
increased number of entries into the OAs (192% on average;
p,0.05) and spent more time in OAs compared with WT mice
(205%; p,0.05), but total distance traveled, an index of activity,
was not significantly different between genotypes (p=0.094)
(Fig. 2B). These results suggest that Hdac6 KO mice have less
anxiety.
To further examine the emotional aspects of Hdac6 KO mice,
we employed the tail suspension test. This is a widely used test for
assessing antidepressant activity by measuring the duration of
immobility during a 6 min session; administration of antidepres-
Figure 2. Abnormal emotional behaviors in Hdac6 KO mice. (A) Hyperactivity of Hdac6 KO mice in the open field test. Total distance traveled
(left), an index of activity, and the number of entries into the center zone (right), an index of anxiety, are indicated (n=24 and 23 for WT and Hdac6
KO mice, respectively). (B) Anxiolytic-like behavior of Hdac6 KO mice in the elevated plus-maze test. Hdac6 KO mice showed increased number of
entries into the open arms (OAs, left) and spent more time in OAs (middle) compared with WT mice, but total distance traveled, an index of activity,
was not significantly different between genotypes (right; n=24 and 23 for WT and KO, respectively). (C) Antidepressant-like behavior of Hdac6 KO
mice in the tail suspension test. Hdac6 KO mice showed decreased immobility compared with WT mice (n=12 for WT and KO mice). (D) Normal home
cage activity of Hdac6 KO mice. Home cage activity of KO mice in both light and dark periods was not distinguishable from that of WT mice (n=5 and
6 for WT and KO, respectively). (E) Normal stress response of Hdac6 KO mice. No genotype differences were found in serum corticosterone levels in
both basal and stressful conditions (n=9, 10, 10, and 10 for control WT, control KO, +stress WT, and +stress KO, respectively). (F) Effect of fluoxetine
on the immobility of WT and Hdac6 KO mice in the tail suspension test (n=18, 18, 12, and 13 for saline WT, saline KO, fluoxetine WT, and fluoxetine
KO, respectively).
doi:10.1371/journal.pone.0030924.g002
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immobility time of Hdac6 KO mice significantly decreased in
75% of WT mice (p,0.05) (Fig. 2C), indicating that Hdac6 KO
mice show antidepressant-like activity.
Behavioral abnormalities observed in Hdac6 KO mice here
seem to be a consequence of emotional arousal. However, there is
still some room for argument about the possibility that behavioral
abnormalities in Hdac6 KO mice are merely due to increased
locomotor activity, which is a key component of many behavioral
tests. In order to assess whether basal locomotor activity was
affected in Hdac6 KO mice, we recorded the home cage activity of
WT and Hdac6 KO mice using an ANIMEX activity meter
(ANIMEX, AB Farad) under a 12-h light/dark cycle for 24 h.
Home cage activity of Hdac6 KO mice in both light and dark
periods, however, was not distinguishable from that of WT mice
(Fig. 2D) as well as circadian rhythms (data not shown). In
addition, no significant difference between WT and Hdac6 KO
mice was observed in neurophysiological screening (Table S1).
These results indicate that the basal locomotor activity and the
neurophysiological functions of Hdac6 KO mice are normal. It
should be noted that the hyperactivity is only induced when Hdac6
KO mice is exposed to novel environment. This result implies that
Hdac6 KO mice exhibit mental abnormality during unfamiliar
environment.
Since stress is considered to be one of the important
contributors in the etiology of depression, we investigated whether
stress state and/or stress response is affected in Hdac6 KO mice.
The hypothalamic-pituitary-adrenal (HPA) axis is a principal
effector of the stress response, and is often activated during
depression owing to impaired negative feedback regulation, which
leads to an increase in serum glucocorticoid [22]. Therefore, we
determined the concentration of serum glucocorticoid (corticoste-
rone in mice) in both basal and stressful conditions induced by the
tail suspension test. However, we found no difference between WT
and Hdac6 KO mice (Fig. 2E). This suggests that the basal activity
of HPA axis as well as stress response is normal in Hdac6 KO mice.
Altogether, we concluded that behavioral abnormalities observed
in Hdac6 KO mice arise from emotional arousal.
To obtain insight into the mechanism of emotional abnormal-
ities of Hdac6 KO mice, we focused on the alteration in the content
of serotonin, an important factor of etiology of depression [20].
Since Hdac6 is concentrated in serotonergic neurons in the dorsal
and median raphe nuclei, Hdac6 depletion in these neurons would
affect serotonin biosynthesis, resulting in change in the content of
serotonin. To examine this, we measured the amount of serotonin
and Tph2, a rate-limiting enzyme of serotonin synthesis in both
WT and Hdac6 KO mice. For measuring serotonin concentration
by immunoassay, we used the whole brain extract, because
serotonergic neurons project to almost all regions of the brain. For
evaluation of the expression level of Tph2, we used raphe nuclei
extract. However, we found no obvious difference in both
serotonin concentration and Tph2 level between WT and Hdac6
KO mice (Fig. S2A and S2B). Moreover, the Tph2 distribution in
the raphe nuclei of Hdac6 KO mice was also not distinguished
from that of WT mice (Fig. 1D). These results suggest that
serotonin synthesis and content in Hdac6 KO mice is normal.
Since acute administration of antidepressants reduces the
immobility in the tail suspension test in mice typically by blocking
serotonin reuptake and enhancing serotonin neurotransmission
[20], it would be expected that Hdac6 KO mice have already been
affected in this process. In an attempt to clarify this issue, we
examined the sensitivity to antidepressant in Hdac6 KO mice. We
injected fluoxetine, a selective serotonin reuptake inhibitor (SSRI),
into Hdac6 KO mice, and evaluated its potency by the tail
suspension test. As a result, fluoxetine significantly decreased the
immobility of Hdac6 KO mice (48% vs. saline control; F
(1,57)=46.2; p,0.0001), and its potency for Hdac6 KO mice was
similar levels to that for WT mice (56% vs. saline control) (Fig. 2F).
Desipramine, a blocker of noradrenalin reuptake, and imipramine,
a serotonin and noradrenalin reuptake inhibitor (SNRI), showed
similar effects in Hdac6 KO mice (Fig. S3). These results suggest
that loss of Hdac6 might not affect the monoamine reuptake
targeted by SSRI/SNRI.
Administration of HDAC6 specific inhibitor leads to
antidepressant-like behavior in mice
To explore whether antidepressant-like behavior in Hdac6 KO
mice is simply due to loss of Hdac6 deacetylase activity, we
adopted an approach to inhibit Hdac6 deacetylase activity in WT
mice. For this purpose, we first tested the specificity of NCT-14b,
one of a series of thiolate analogues that inhibit HDAC6 [23].
Since HDAC6 is localized exclusively in the cytoplasm and
deacetylates a-tubulin [6,7,24], inhibition of Hdac6 activity would
increase the amount of acetylated a-tubulin, but not that of
acetylated histones. As expected, NCT-14b treatment of the HeLa
cells increased the acetylation of a-tubulin but not that of histone
H3, demonstrating the specificity of NCT-14b for HDAC6
(Fig. 3A). In contrast, sodium butyrate, a well-known class I
HDAC inhibitor that does not inhibit HDAC6, only increased the
acetylation of histone H3, while a non-specific potent HDAC
inhibitor, trichostatin A (TSA), increased the acetylation of both a-
tubulin and histone H3 (Fig. 3A).
In the tail suspension test, intraperitoneal administration of
NCT-14b significantly reduced the immobility of WT mice (79%
vs. saline-injected control; F (1,63)=4.22; p=0.044) (Fig. 3B). In
contrast, the same amount of NCT-14b had little effect on the
immobility of Hdac6 KO mice, indicating that NCT-14b targets
Hdac6 to reduce immobility. It should be noted that the
immobility-reducing effect of NCT-14b reached at almost equal
to that of Hdac6 gene knockout (75% vs. WT mice; p,0.05; see
Fig. 2C). This indicates that the antidepressant-like behavior of
Hdac6 KO mice is not only due to the long-term effect of gene
depletion, but also caused by the transient loss of Hdac6
deacetylase activity in the adult brain. To evaluate the inhibition
potency of NCT-14b in vivo, brains of two mice from each group in
Figure 3B were isolated, and then the acetylation level of a-tubulin
was examined. As expected, NCT-14b treatment modestly
increased the amount of acetylated a-tubulin in WT mice brain
(Fig. 3C). To examine the local effects in the raphe nuclei of NCT-
14b administration on a-tubulin acetylation , we injected same
concentration of NCT-14b into WT mice, and evaluated the levels
of a-tubulin acetylation in isolated raphe nuclei specimen. As
shown in Figure S4, modest increase of a-tubulin acetylation was
observed in raphe nuclei of NCT-14b-injected mice. These results
confirm the validity of NCT-14b in in vivo application, and
demonstrate that inhibition of the deacetylase activity of Hdac6
causes antidepressant-like behavior in mice.
Discussion
In the present study, we provided evidence that non-histone
protein acetylation plays an important role in CNS by focusing on
Hdac6, a multifunctional cytoplasmic deacetylase. We demon-
strated that disturbance of Hdac6-mediated protein deacetylation
both by gene knockout and by chemical inhibition of deacetylase
activity results in behavioral consequences related to emotion in
mice. Emotional features such as fear and depression are known to
be closely associated with the serotonergic system. In good
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neurons in the dorsal and median raphe nuclei, the origin of the
ascending serotonergic fibers innervating the forebrain and
amygdala [25,26]. Thus, it is plausible that Hdac6-mediated
reversible acetylation in serotonergic neurons regulates its
neuronal functions.
Recently, an antidepressant-like effect of HDAC inbitors, N-(2-
aminophenyl)-4-[N- (pyridine-3-ylmethoxy-carbonyl) amino-
methyl]benzamide (MS-275; classI HDACs inhibitor) and sub-
eroylanilide hydroxamic acid (SAHA; class I and II HDACs
inhibitor), in social defeat paradigms has been reported in mice
[27]. Moreover, Hdac2 deficiency as well as chronic treatment
with SAHA in mice leads to memory facilitation by increasing the
synapse number in hippocampus CA1 region [28]. In these
reports, transcriptional regulation controlled by the dynamic
change of histone acetylation either in the nucleus accumbens [27]
or hippocampus [28] is responsible for antidepressant-like effect or
memory facilitation, respectively. In contrast, since the level of
histones acetylation is not affected by both Hdac6 gene knockout
(Fig. S2B) [24] and chemical inhibition of HDAC6 activity in Hela
cells (Fig. 3A), it is clear that abnormality of emotional behavior
caused by Hdac6 inhibition does not result from alteration of
transcriptional regulation. To our knowledge, this is the first report
to identify the association between non-histone protein acetylation
and higher brain function.
The elevated plusmaze test and the tail suspension test, adopted
in this study, are well-established behavioral experiments assessing
the anxiety and depression, respectively. Although Hdac6 KO mice
exhibited less anxiety and antidepressant-like activity in these tests,
we should point out the possibility that such behavior is, in part,
responsible for increased locomotor activity under a novel
environment. In this regard, we consider that such novelty-
induced abnormal hyperactivity represents emotional problems.
Although, at present, the molecular mechanism of how
inhibition of Hdac6-mediated protein deacetylation leads to
hyperactivity, less-anxiety, and antidepressant-like activity still
remains elusive, we have obtained some insight into this issue.
First, the mechanism underlying antidepressant-like behavior
observed in both Hdac6 KO mice and NCT-14b-injected WT
mice might be different from that of current antidepressants,
which target serotonin and noradrenalin transporters and enhance
the neurotransmission [20]. Our results showing that the
antidepressants are still effective in Hdac6 KO mice in the tail
suspension test (Fig. 2F) and serotonin content is not affected in
Hdac6 KO mice (Fig. S2A) support this view. Second, Hdac6 may
contribute to regulate emotional behavior by deacetylating other
Hdac6 substrate(s) besides a-tubulin. It should be noted that the
amount of acetylated a-tubulin in NCT-14b-injected WT mice
brain as well as dorsal raphe region does not reach the same level
as that of Hdac6 KO mice (Figs. 3C, S4) even though NCT-14b
fully affects the immobility in WT mice (Fig. 3B). Thus, there is a
discrepancy between acetylation levels of a-tubulin and immobility
in NCT-14b-injected mice, and it raises the possibility that Hdac6
has a specific substrate other than a-tubulin in serotonergic
neurons. Further study is needed to find a specific target for
Hdac6, which would be a key for serotonergic function associated
with an antidepressant-like behavioral response.
Our findings also suggest that HDAC6-mediated reversible
acetylation can become a new therapeutic target for depression.
Since NCT-14b seems to act as a non-monoamine-based
antidepressant, HDAC6 inhibitors may have potential as medi-
cines to overcome the disadvantage of current antidepressants,
namely, their requirement of at least several weeks for therapeutic
action [20]. Identification of HDAC6 substrates and related
cellular processes in serotonergic neurons associated with the
expression of antidepressant-like behavior will bring new insights
into the molecular basis of mood disorders.
Materials and Methods
Animals
Hdac6 KO mice [10] were backcrossed at least six times with
129SV background. Because Hdac6 gene is located on X
chromosome [3], male mice carrying the mutant allele are null
for Hdac6. Mice were maintained on a 12-h light/dark cycle
(lights on at 7:00 AM) and were allowed access to food and water
ad libitum. We used male mice at 3–12 months of age for all
experiments. All experimental procedures in this study and
housing condition were reviewed and approved by the animal
experimentation committee of the Institute for Developmental
Research in Aichi Human Service Center (Permit number: M-19).
Figure 3. Inhibition of Hdac6 deacetylase activity causes antidepressant-like effect. (A) A NCT-14b (14b) treatment of the HeLa cells
increased the amount of acetylated-a-tubulin (Ac-a-Tub) but not that of histone H3. HDAC6 and actin were shown as loading controls. (B) Effect of
NCT-14b on the immobility of WT and Hdac6 KO mice in the tail suspension test (n=14, 21, 16, and 16 for saline WT, saline KO, NCT-14b WT, and NCT-
14b KO, respectively). (C) Effect of NCT-14b on a-tubulin acetylation in mouse brain. Amount of acetylated a-tubulin in the brain extract after the tail
suspension test in (B) was determined by Western blotting. Lower panel shows quantification of Ac-a-Tub normalized by actin.
doi:10.1371/journal.pone.0030924.g003
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Rabbit polyclonal antibody against mouse Hdac6 was as
described previously [10]. Anti-acetylated lysine monoclonal
antibody (clone AKL5C1) was generously provided by Dr. Minoru
Yoshida (RIKEN, Saitama, Japan). Anti-histone H3 rat monoclo-
nal antibody was generous gift from Dr. Hiroshi Kimura (Osaka
University, Osaka, Japan) [29]. Commercially available antibodies
for a-tubulin (Cedarlane), Lys40-acetylated a-tubulin (Sigma),
human HDAC6 (C300, Santa Cruz Biotechnology), acetylated
histone H3 (Millipore), tryptophan hydroxylase 2 (NB100-74555,
Novus biologicals), and pan-actin (NeoMarkers) were also used in
this study. For the double immunostaining procedure, rabbit
polyclonal antibody against mouse Hdac6 was directly coupled
with the Alexa Fluor 555 dye using the Alexa Fluor 555
Monoclonal Antibody Labeling Kit (Invitorgen) according to the
manufacturer’s instructions.
Chemicals
Fluoxetine hydrochloride, desipramine hydrochloride, and
imipramine hydrochloride were purchased from Sigma. These
drugs were dissolved in saline and injected intraperitoneally in a
volume of 10 ml/kg body weight 30 min prior to testing. Drug
doses were 25 mg/kg imipramine, 30 mg/kg fluoxetine, and
20 mg/kg desipramine. These effective doses were chosen on the
basis of previous reports on mice [21]. Trichostatin A (TSA) and
sodium butyrate were purchased from Sigma. An HDAC6-
selective inhibitor, the compound (S)-S-7-(adamant-1-ylamino)-6-
(tert-butoxycarbonyl)-7-oxoheptyl-2-methylpropanethioate (NCT-
14b) [23], dissolved in saline at 4.8 mg/kg, was injected
intraperitoneally in a volume of 10 ml/kg body weight 24 h prior
to testing. We compared the effects of NCT-14b treatment period
either 30 min or 24 h by the tail suspension test and found that
24 h treatment more effectively reduced immobility of WT mice
(our unpublished data).
Behavioral procedures
All behavioral procedures were undertaken during the light
period under 100 lux light intensity. Before behavioral testing,
mice were placed in an experimental room for 30 min prior to
testing. For the open field test, a mouse was placed in the center of
an open field apparatus (white wooden box: 40640620 cm,
divided into 9 even-sized squares (13613 cm)), and recorded using
a video camera positioned above the apparatus. The total distance
traveled in the open field was recorded for 10 min to measure the
horizontal activity. The number of entries into the square at the
center of the field was counted to evaluate anxiety. For the
elevated plus-maze test, a mouse was placed into the center of the
plus-maze apparatus (Ohara-Ika Sangyo), which was raised 50 cm
above the floor, consisting of two open arms (40 cm long by 10 cm
wide) and two enclosed arms of the same size with walls 20 cm
high, and recorded using a video camera positioned above the
apparatus. The number of entries into the open arms was counted
over a 10 min test session to evaluate anxiety. A video-tracking
system with computer interface and video camera (Any-maze;
Stoelting) was used to automatically collect behavioral data. In this
system, the animal’s entries into defined areas of the apparatus
were counted when 80% of animal’s entire area was onto
respective zone. For the tail suspension test, a mouse was fastened
by the distal end of the tail to a plastic clip (Yamashita-Giken) and
was suspended in a white wooden box (40625625 cm). The
presence of immobility, defined as the absence of any movement,
was counted over a 6 min test session by a highly trained observer
who remained blind to genotype and treatment. For the analysis of
home cage activity, home cage with a mouse was placed on an
ANIMEX activity meter (AB Farad) and mouse activity was
measured for 24 h.
Immunohistochemistry
For immunohistochemistry, mice were anesthetized and
transcardially perfused with phosphate-buffered saline (PBS)
followed by 4% paraformaldehyde in PBS. Brains were removed
and cryostat sections (10 mm thick, coronal sections) were prepared
with standard protocols. For double immunostaining for Hdac6
and TPH2, the brain section was firstly reacted with anti-TPH2
antibody (1:200 dilution), followed by Cy2-conjugated secondary
antibody, and then fixed by 3% paraformaldehyde in PBS. Next,
the section was reacted with the Alexa Fluor 555 labeled anti-
mouse Hdac6 antibody and 49,69-diamidino-2-phenylindole
(DAPI) to visualize Hdac6 and the nuclei, respectively. The
immunofluorescent signals were observed under confocal laser
scanning microscopy (FLUOVIEW FV1000; Olympus). For the
detection of human HDAC6 in postmortem human brain, paraffin
sections (5 mm thick, coronal sections) were prepared with
standard protocols. Sections spanning raphe and locus ceruleus
were derived from adult human brain, and sections spanning
substantia nigra were from a newborn infant brain. Paraffin
sections were stained with anti-human HDAC6 antibody (1:200
dilution) followed by HRP-labeled secondary antibody, and were
observed by light microscopy (BX61; Olympus). All experimental
procedure using postmortem human brain have been reviewed
and approved by the Human Ethics Committee of the Institute for
Developmental Research in Aichi Human Service Center
(approved number: 03-02).
Biochemical analysis
To confirm the specificity of NCT-14b, HeLa cells (purchased
from ATCC) were treated with NCT-14b (1 mM), TSA (0.1 mM),
or sodium butyrate (5 mM) for 1 h. Then, cells were lysed in
Laemmli sample buffer and subjected to Western blotting with
antibodies against acetylated a-tubulin (1:2000 dilution), acetylat-
ed histone H3 (1:1000 dilution), human HDAC6 (1:1000 dilution),
and actin (1:2000 dilution). For the quantification of acetylated a-
tubulin in the brain, each mouse was killed by cervical dislocation,
and brain was quickly removed and homogenized in 5 ml of buffer
(5 mM Tris-HCl pH7.6, 0.32 M sucrose, 1 mM EDTA, 1 mM
TSA) with a glass-teflon homogenizer. The homogenates were
centrifuged at 1000 g for 10 min to remove nuclei and debris. The
supernatants (brain extract) were then subjected to Western
blotting with an ECL detection system (GE Healthcare) as
described previously [30]. The dorsal raphe-containing slice
(2 mm thick) of mouse brain was cut out with razor blades
directed by a chilled precision brain slicer (BS-2000C, Braintree
Scientific, Inc.), and the dorsal raphe region were trimmed with a
1 mm biopsy punch (BP-10F, Kai Industries Co. Ltd) and
processed for Western blotting. Serum corticosterone concentra-
tion was determined by immunoassay according to the manufac-
turer’s instructions (AssayMax Corticosterone ELISA Kit, Assay-
pro). To evaluate the stress response, serum was prepared 30 min
after the end of the tail suspension test, and was subjected to
immunoassay. The serotonin concentration of both serum and
brain extract was measured by immunoassay according to the
manufacturer’s instructions (Serotonin ELISA kit, GenWay
Biotech).
Statistical analysis
Student’s t test was used for statistical comparison (Figs. 2A–C,
S1A). For multiple comparisons, groups were compared using two-
way analysis of variance, followed by Bonferroni’s post hoc test
Protein Acetylation and Emotional Behavior
PLoS ONE | www.plosone.org 6 February 2012 | Volume 7 | Issue 2 | e30924(Figs. 2E, 2F, 3B and S3). The data are presented as mean 6
s.e.m., n indicates the sample number, and p denotes the
significance (*p,0.05, **p,0.01, ***p,0.001).
Supporting Information
Figure S1 Abundant expression of Hdac6 in the brain
and testis in mice. Two micrograms of tissue extract was
analyzed by Western blotting with anti-Hdac6 antibody.
(TIF)
Figure S2 Normal serotonin content in Hdac6 KO mice.
(A) Serotonin concentration of both brain extracts and serum of
Hdac6 KO mice was determined by immunoassay. Serotonin
concentrations of Hdac6 KO mice were comparable to that of WT
mice (brain extracts; WT, 18.861.2 ng/mg protein (n=5), Hdac6
KO mice, 20.462.3 ng/mg protein (n=6), serum; WT,
1154 ng643 ng/mg protein (n=3), Hdac6 KO mice,
12746252 ng/mg protein (n=4). (B) The expression levels of
indicated proteins in dorsal raphe region of WT and Hdac6 KO
mice brain were analyzed by Western blotting. Acetylation level of
a-tubulin in Hdac6 KO mice was higher than that of WT mice. In
contrast, the acetylation of histone H3 in Hdac6 KO mice was
similar to WT mice. The Tph2, a rate limiting enzyme of
serotonin synthesis in the brain, was abundant in dorsal raphe
compared to cortex, and the amount of Tph2 in Hdac6 KO mice
was comparable to that of WT mice. The amount of a-tubulin,
histone H3 and actin were shown as loading controls.
(TIF)
Figure S3 Effects of imipramine and desipramine on
Hdac6 KO mice in the tail suspension test. Effects of acute
injection of imipramine (25 mg/kg) and desipramine (20 mg/kg)
on the immobility of WT and Hdac6 KO mice in the tail
suspension test was investigated. Imipramine significantly reduced
both immobility times of WT (56% on average) and Hdac6 KO
mice (59%) compared with each of saline-injected control mice
(n=18, 19, 18, and 16 for saline WT, saline KO, imipramine WT,
and imipramine KO, respectively; F (1,67)=39.47; p,0.0001).
Desipramine showed similar results as reducing immobity of WT
(62%) and Hdac6 KO mice (60%) (n=18, 18, 11, and 12 for saline
WT, saline KO, desipramine WT, and desipramine KO,
respectively; F (1,55)=76.52; p,0.0001). Data were presented as
mean 6 s.e.m., and statistically analyzed by two-way analysis of
variance followed by Bonferroni’s post hoc test.
(TIF)
Figure S4 Effects of NCT-14b administration on tubulin
acetylation in dorsal raphe. Amounts of acetylated a-tubulin
(Ac-a-Tub) in cortex and dorsal raphe 24 h after NCT-14b
administration were analyzed by Western blotting. Lower panel
showed quantification of Ac-a-Tub normalized by a-tubulin (a-
Tub). Although NCT-14b (14b) slightly increased the amount of
Ac-a-Tub in dorsal raphe, it did not reach the same level as that of
Hdac6 KO mice (KO). The effect of NCT-14b was more
pronounced in motor cortex than in dorsal raphe.
(TIF)
Table S1 Neurophysiological screen in WT and Hdac6
KO mice.
(TIF)
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